Despite improved antiretroviral regimens, virological failure and the emergence of drug resistance is still a problem worldwide. This includes both patients recently infected and those veterans of older regimens. Overall, viral suppression among people living with HIV in the USA is 55% and adherence is often sub-optimal. Ultimately, this leads to an increasing number of HIV patients with limited treatment options. These complex HIV patients require greater knowledge and understanding to manage in terms of adherence, resistance, aging, comorbidities, and polypharmacy.
This webinar was designed for US HIV physicians who would like to improve their knowledge on identifying and managing patients with limited treatment options, as well as new antiretroviral drugs for optimizing treatment of these patients.
The interactive 1.5 hour Webinar was held on 15 September 2020 at 12:00 EDT and included the most up-to-date information from international experts.
